等待开盘 01-28 09:30:00 美东时间
+0.012
+1.49%
今日重点评级关注:RBC Capital:维持Compass Pathways"跑赢大市"评级,目标价从16美元升至21美元;RBC Capital:维持GH Research"跑赢大市"评级,目标价从33美元升至40美元
01-26 14:32
Ladenburg Thalmann analyst Kevin DeGeeter initiates coverage on Decoy Therapeutics (NASDAQ:DCOY) with a Buy rating and announces Price Target of $2.5.
01-23 20:29
Decoy Therapeutics will use the platform, with funding support from the Gates Foundation, to provide widespread access to peptide-conjugate antivirals from Decoy's IMP3ACT™ platform for low- and middle-income
01-13 21:20